EXC vs REPL
Exelon Corporation (EXC) versus Replimune Group Inc (REPL) — a side-by-side from cached financials, not a winner call.
Exelon Corporation (EXC) is a utilities - regulated electric company listed on NASDAQ.
Replimune Group Inc (REPL) is a biotechnology company listed on NASDAQ.
Latest reported EXC revenue for 2024-12-31 was $23.03B. Net income was $2.46B. Revenue was up 6.0% from 2023-12-31 to 2024-12-31. EXC currently screens at market cap $47.33B and trailing P/E 16.8.
REPL does not have a complete income-statement cache yet.
EXC currently screens at market cap $47.33B and trailing P/E 16.8. REPL currently screens at market cap $825.7M.
Not investment advice. Open the EXC and REPL stock pages for the full models.
Not investment advice.